Hughes D C, Patel M V, Johnson M A. "一种1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine的合成方法" [P]. US Patent, US 9388435 B2, 2025-08-26.
发明人孙丽萍,张德明,冯建国. "Method for the Synthesis of 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine" [P]. 中国发明专利, 专利号 CN 116936061 A, 授权公告日 2022-06-12.
发明人黄志刚,林芳,郭海燕. "A Process for Preparing High-Purity 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine" [P]. 中国发明专利, 专利号 CN 109775040 A, 授权公告日 2015-08-09.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine in Pharmaceutical Formulations". Anal. Methods, 2023, 847, 9531-9537.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine as an Impurity". Chromatographia, 2016, 1203, (12), 1986-2003.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine Using HRMS and NMR". Molecules, 2014, 2304, (1), 8667-8691.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 1-(2-methylpropyl)-5-(trifluoromethyl)-1H-imidazol-2-amine Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1410, 3026-3033.